5% Taurine Eye Drops 10mL | Cornea Nourishing & Ocular Fatigue Relief

5% Taurine Eye Drops 10mL: What the Published Guidance Says

Fifteen ophthalmic products spanning anti-infective, anti-allergic, anti-inflammatory, antiviral and ocular-surface categories — including the two anti-infectives the WHO Model List names for conjunctivitis and infectious keratitis.

Buyers usually settle three things before ordering 5% Taurine Eye Drops 10mL: the pharmacopoeial monograph, the pack configuration, and the documents the destination authority will ask for.

• Trachoma and endophthalmitis have separate recommendations For trachoma the treatment of choice is a single oral dose of azithromycin, with topical azithromycin or tetracycline also indicated. For bacterial endophthalmitis, the listings for ceftazidime, ceftriaxone and vancomycin were extended to cover it as a first-choice option, with the Committee noting that intravitreal administration requires specialist training and adequate infrastructure. WHO eEML — Ofloxacin (ophthalmological)
• Gentamicin eye drops 0.3% are on the Model List for ocular infection WHO lists gentamicin eye drops 0.3% (gentamicin sulfate) for infectious blepharitis, classified in the Access group of the AWaRe framework. The Expert Committee has specified amikacin, kanamycin, netilmicin and tobramycin as therapeutic alternatives under the gentamicin square-box listing. WHO eEML — Gentamicin (ophthalmological)
• Evidence for conjunctivitis does not favour one antibiotic over another The Committee noted that topical antibiotics are indicated for moderate to severe infection and can be considered in mild cases, but that available evidence does not make it possible to identify specific, preferred antibiotics for conjunctivitis. It therefore endorsed the existing gentamicin and tetracycline listings rather than picking a winner. WHO eEML — Ofloxacin (ophthalmological)

Each point above is reproduced because it has a practical consequence for 5% Taurine Eye Drops 10mL: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.

Testing, Monographs & Batch Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Release testing for 5% Taurine Eye Drops 10mL follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The batch record for this product normally includes:

• Testing for assay of the active substance
• Testing for related substances and impurities
• Testing for dissolution or release profile (solid oral forms)
• Testing for uniformity of dosage units
• Testing for water content and pH where applicable
• Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Pack Configuration, Artwork & Shipping Documents

• Pack size: Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Non-standard pack sizes can be quoted against your artwork.
• Storage: Store at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening..
• Shelf life: 24 months unopened; discard within 4 weeks of first opening. Stability data for the marketed pack is included in the dossier.
• Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
• Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Dossier, Authority Filings & Tender Documentation

The legal manufacturer named on every document for 5% Taurine Eye Drops 10mL is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.

• Site Master File and GMP certificate for the manufacturing workshops.
• Method validation, stability protocol and the shelf-life justification for the marketed pack.
• Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
• Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
• Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.

5% Taurine Eye Drops 10mL is presented here against ophthalmic preparations used in WHO and MSF eye-care protocols. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.

Other Ophthalmic Products in This Range

• 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL — 10mL
• 1% Acyclovir Eye Drops 10mL — 10mL
• 0.5% Chloramphenicol Eye Drops 10mL — 10mL
• 0.3% Gentamicin Eye Drops 10mL — 10mL
• 0.5% Hypromellose Eye Drops 10mL — 10mL
• 0.5% Kanamycin Eye Drops 10mL — 10mL

Browse the full Ophthalmic range; all Ophthalmic; the complete product catalogue.